These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34102)

  • 1. Biological aspects of cannabis use.
    Stefanis C
    NIDA Res Monogr; 1978; (19):149-78. PubMed ID: 34102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and its problems.
    Paton WD
    Proc R Soc Med; 1973 Jul; 66(7):718-21. PubMed ID: 4582312
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychiatric aspects of cannabis use in adolescents and young adults.
    Tunving K
    Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between non-acute adolescent cannabis use and cognition.
    Harvey MA; Sellman JD; Porter RJ; Frampton CM
    Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cannabis on information-processing speed.
    Kelleher LM; Stough C; Sergejew AA; Rolfe T
    Addict Behav; 2004 Aug; 29(6):1213-9. PubMed ID: 15236825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the long-term pharmacological research on cannabis.
    Chruściel TL
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):57-62. PubMed ID: 1165142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
    Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
    Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users.
    Nestor L; Roberts G; Garavan H; Hester R
    Neuroimage; 2008 Apr; 40(3):1328-39. PubMed ID: 18296071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are cannabis substances dangerous?].
    Retterstol N
    Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1754-7. PubMed ID: 4771909
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
    Khiabani HZ; Mørland J; Bramness JG
    Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive and psychotic effects after cessation of chronic cannabis use].
    van Amsterdam JG; van der Laan JW; Slangen JL
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):504-8. PubMed ID: 9623095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cannabis use on health].
    Negrete JC
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):267-76. PubMed ID: 6324549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.